Ticker: CME

CME Group

Finance Financials Financial - Data & Stock Exchanges
Price 274.07
Reco Hold Potential 63 Risk 42 Updated 2026-09-10

Forecast impact

neutral
Target -1.7% target fill 101.7%
Reaction D5 -3.53% · D10 -5.21%
Impact Potential 0 · Risk 0 valid until 2026-09-18

Track in portfolio

Price chart

AI recommendation Analyst forecast Calendar event Positive signal Negative signal Neutral / update Hold / informational B My buy S My sell
Description

Company and Business Model

CME Group operates as a global markets company, providing trading and clearing services across various asset classes, including derivatives, options, and futures. Its core products encompass commodities, financials, and equity indices. Major business segments include the CME, CBOT, NYMEX, and COMEX exchanges. The primary revenue sources are transaction fees, market data services, and clearing services, driven by trading volumes and market activity.

Investment Profile

The investment profile of CME Group is characterized by a balanced approach, appealing to investors seeking both growth and income through dividends. The company offers a competitive dividend yield, alongside potential for capital appreciation driven by market activity. This profile suits investors with a medium to long-term horizon, looking for stability and moderate risk.

Fundamental metrics (experimental) Updated: 2026-09-10
EPS (TTM) — earnings per share for the last 12 months, $
11.80
Revenue QoQ — quarter-over-quarter revenue growth
14.0%
EPS surprise
0.7%
20d volatility
1.2%
Dividend yield
3.7%
last ex-date
2026-03-10
AI recommendation changes
Date Before After Reason
2026-09-06 Buy Hold Strong fundamentals, but mixed momentum and market signals.
2026-08-27 Hold Buy Strong fundamentals and positive momentum support growth potential.
2026-08-20 Buy Hold Solid fundamentals, but negative momentum raises concerns.
Analyst forecasts
Date Analyst Action Target Price Then
2026-08-19 Deutsche Bank Rating Downgraded — → 270 271.54
2026-07-23 Morgan Stanley Target Raised 324 → 330 252.8
2026-07-15 Piper Sandler Target Lowered 329 → 295 243.61
News Page 1 of 3
Robinhood Nasdaq CME Group

CFTC’s Innovation Advisory Committee Discusses Regulation of Prediction Markets and Emerging Risks

The CFTC's Innovation Advisory Committee convened to address regulatory concerns surrounding prediction markets, particularly focusing on self-certification processes and the risks associated with 'mention markets.' This meeting is significant as it may shape future regulations that impact how these markets operate and their susceptibility to manipulation.